FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
-3.32%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$68M
AUM Growth
+$68M
(-16%)
Cap. Flow
-$10.5M
Cap. Flow
% of AUM
-15.5%
Top 10 Holdings %
Top 10 Hldgs %
55.84%
Holding
220
New
38
Increased
14
Reduced
19
Closed
48
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$3.58M |
| 2 |
Constellation Brands
STZ
|
$3.07M |
| 3 |
General Mills
GIS
|
$2.28M |
| 4 |
Gilead Sciences
GILD
|
$2.21M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$2M |
Top Sells
| 1 |
Procter & Gamble
PG
|
$4.04M |
| 2 |
Bristol-Myers Squibb
BMY
|
$3.97M |
| 3 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$3.19M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.56M |
| 5 |
iShares Biotechnology ETF
IBB
|
$2.03M |
Sector Composition
| 1 | Healthcare | 57.22% |
| 2 | Consumer Staples | 17.99% |
| 3 | Consumer Discretionary | 5.6% |
| 4 | Financials | 5.26% |
| 5 | Communication Services | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MON
26
DELISTED
Monsanto Co
MON
| $737K | 0.85% |
7,001
-10,312
| -60% | -$1.09M |
|
27
Vertex Pharmaceuticals
VRTX
$100B
| $703K | 0.81% |
9,548
+2,854
| +43% | +$210K |
|
28
Alibaba
BABA
$330B
| $699K | 0.8% |
7,955
+3,855
| +94% | +$339K |
|
29
United Therapeutics
UTHR
$13.8B
| $699K | 0.8% |
4,873
-5,693
| -54% | -$817K |
|
30
Adobe
ADBE
$147B
| $649K | 0.75% |
+6,300
| New | +$649K |
|
31
Mondelez International
MDLZ
$80B
| $609K | 0.7% |
+13,734
| New | +$609K |
|
|
BIG
32
DELISTED
Big Lots, Inc.
BIG
| $573K | 0.66% |
+11,422
| New | +$573K |
|
33
Chipotle Mexican Grill
CMG
$56B
| $563K | 0.65% |
+1,492
| New | +$563K |
|
|
NBRV
34
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $494K | 0.57% |
83,055
+25,000
| +43% | +$149K |
|
35
Colgate-Palmolive
CL
$67.9B
| $438K | 0.5% |
+6,700
| New | +$438K |
|
36
NVIDIA
NVDA
$4.16T
| $427K | 0.49% |
+4,000
| New | +$427K |
|
37
Larimar Therapeutics
LRMR
$310M
| $420K | 0.48% |
131,930
| – | – |
|
38
Accenture
ACN
$162B
| $406K | 0.47% |
+3,467
| New | +$406K |
|
|
YHOO
39
DELISTED
Yahoo Inc
YHOO
| $387K | 0.44% |
10,000
-20,341
| -67% | -$787K |
|
40
SCYNEXIS
SCYX
$34.9M
| $382K | 0.44% |
119,905
-10,828
| -8% | -$34.5K |
|
41
Kellanova
K
$27.6B
| $381K | 0.44% |
+5,172
| New | +$381K |
|
42
Charter Communications
CHTR
$36.3B
| $373K | 0.43% |
1,296
-19
| -1% | -$5.47K |
|
43
Esperion Therapeutics
ESPR
$448M
| $365K | 0.42% |
+29,193
| New | +$365K |
|
44
uniQure
QURE
$896M
| $365K | 0.42% |
65,158
+35,000
| +116% | +$196K |
|
|
NBIS
45
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.7B
| $329K | 0.38% |
16,367
+4,367
| +36% | +$87.8K |
|
46
Best Buy
BBY
$15.6B
| $316K | 0.36% |
7,400
+3,946
| +114% | +$169K |
|
47
Domino's
DPZ
$15.6B
| $287K | 0.33% |
+1,800
| New | +$287K |
|
48
Papa John's
PZZA
$1.6B
| $273K | 0.31% |
+3,191
| New | +$273K |
|
49
Teva Pharmaceuticals
TEVA
$21.5B
| $263K | 0.3% |
7,250
-24,050
| -77% | -$872K |
|
50
Veeva Systems
VEEV
$44.1B
| $253K | 0.29% |
+6,219
| New | +$253K |
|